Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1521
  • Embargo expired:
    5-Dec-2018 5:05 AM EST

Article ID: 704825

Scientists Identify ‘Youth Factor’ in Blood Cells That Speeds Fracture Repair

Duke Health

Duke Health researchers have previously shown that introducing bone marrow stem cells to a bone injury can expedite healing, but the exact process was unclear. Now, the same Duke-led team believes it has pinpointed the “youth factor” inside bone marrow stem cells -- it’s the macrophage, a type of white blood cell, and the proteins it secretes that can have a rejuvenating effect on tissue. Nature Communications will publish the findings online on Dec. 5.

3-Dec-2018 4:35 PM EST

Article ID: 704927

NEI awards prize for progress toward developing lab-made retinas

NIH, National Eye Institute (NEI)

The National Eye Institute (NEI) awarded $25,000 to a team led by Wei Liu, Ph.D., Albert Einstein College of Medicine, for demonstrating progress toward the development of a living model of the human retina, the light-sensitive tissue at the back of the eye. The prize money was awarded for the first of two phases of the NEI 3-D Retina Organoid Challenge 2020 (3-D ROC 2020), a national initiative to generate human retina organoids from stem cells. NEI is part of the National Institutes of Health.

4-Dec-2018 5:05 PM EST
  • Embargo expired:
    4-Dec-2018 4:00 PM EST

Article ID: 704677

Expanded Cord Blood Shows Potential for Use in Adult Bone Marrow Transplants

Duke Health

Umbilical cord blood stem cells that are cultured and expanded outside the body before being used for bone marrow transplant in adult blood cancer patients appear safe and restore blood count recovery faster than standard cord blood. The findings, led by a Duke Cancer Institute researcher, advance efforts to improve cord blood use among adults who have been diagnosed with blood cancers.

30-Nov-2018 10:05 AM EST
  • Embargo expired:
    1-Dec-2018 12:00 PM EST

Article ID: 704734

CAR-T cell update: therapy improves outcomes for patients with B-cell lymphoma

University of Chicago Medical Center

An international phase-2 trial of a CAR-T cell therapy—to be published on-line Dec. 1 in the New England Journal of Medicine (and presented at the ASH annual meeting in San Diego)—found that 52% of patients responded favorably to the therapy; 40% had a complete response and 12% had a partial response. One year later, 65% of those patients were relapse-free, including 79% of complete responders. The median progression-free survival “has not been reached.”

30-Nov-2018 4:00 PM EST

Article ID: 704645

Memorial Sloan Kettering Researchers at ASH Annual Meeting

Memorial Sloan Kettering Cancer Center

MSK experts in CAR-T therapy, immunotherapy, leukemia, lymphoma, blood and marrow stem cell transplantation, and more, are also available to comment on meeting news.

29-Nov-2018 3:05 PM EST
  • Embargo expired:
    26-Nov-2018 3:00 PM EST

Article ID: 704346

Citrate-based Biomaterial Fuels Bone Healing with Less Rejection

Penn State Materials Research Institute

A material based on a natural product of bones and citrus fruits, called citrate, provides the extra energy stem cells need to form new bone tissue, according to a team of Penn State bioengineers.

26-Nov-2018 8:00 AM EST

Article ID: 704315

’Longevity Protein’ Rejuvenates Muscle Healing in Old Mice

Health Sciences at the University of Pittsburgh

A protein found in healing muscles of younger mice helps older animals bounce back from injury.

21-Nov-2018 12:05 PM EST

Article ID: 704272

Complimentary Press Registration Available for 2019 Winter Rheumatology Symposium

American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) welcomes members of the press to write about rheumatology research presented the Winter Rheumatology Symposium in Snowmass Village, CO on January 26 to February 1, 2019.

21-Nov-2018 11:05 AM EST
  • Embargo expired:
    15-Nov-2018 11:00 AM EST

Article ID: 703896

Brain, muscle cells found lurking in kidney organoids grown in lab

Washington University in St. Louis

New research has identified rogue cells – namely brain and muscle cells – lurking within kidney organoids. The presence of such cells indicates that the “recipes” used to coax stem cells into becoming kidney cells inadvertently are churning out other cell types.

13-Nov-2018 11:05 AM EST

Showing results

110 of 1521

Chat now!